RadNet Acquires Gleamer: The Radiology AI Platform Consolidation Thesis Takes Shape
This is an excerpt of Marketstrat’s full strategic analysis. The complete research note — including detailed competitive landscape analysis, integration risk assessment, and company profiles — is available to clients. EXECUTIVE SUMMARY On March 2, 2026, RadNet, Inc. (NASDAQ: RDNT) completed its acquisition of Gleamer SAS, a Paris-based radiology AI company, for up to €230 […]
Imaging AI Goes Infrastructure; Cloud PACS and MIS Platforms Compete for Scale
OEM-provider alliances, cloud enterprise imaging, and CPT signals accelerate distribution-led adoption across radiology and Minimally Invasive Surgery. ONE BIG THING Enterprise imaging is being purchased as infrastructure—alliances + cloud + scaled reporting networks—while MIS platforms apply the same “bundle + workflow” playbook. KEY TAKEAWAYS LATE-BREAKING UPDATE (March 2, 2026 — post-publication window) RadNet to Acquire […]
The Marketstrat Pulse — Tariff Reset + Outcomes‑Grade AI: Imaging Economics Meets Surgical Robotics (Week Ending Feb 20, 2026)
ONE BIG THING Capacity economics is replacing algorithm novelty as imaging AI’s core battleground — validated this week by MASAI’s workload evidence, GE’s throughput-focused MRI clearances, and a tariff ruling that shifts OEM procurement conversations from cost volatility to capacity outcomes. KEY TAKEAWAYS QUICK GLANCE TABLE Date Headline Our Take Source 2026-02-20 Supreme Court limits […]
The Marketstrat Pulse — Clearances, Channels, and Coverage Risk: Imaging AI Becomes Enterprise Infrastructure (Feb 13, 2026)
ONE BIG THING Imaging AI’s scaling constraint is shifting from model performance to “get paid + get distributed,” as Median’s end‑to‑end lung cancer screening clearance and Tempus Pixel distribution move collide with a fragile CMS OPPS payment construct that can swing AI software reimbursement by ~9× based on claims data. KEY TAKEAWAYS INNOVATION HOOK The […]
The Marketstrat Pulse — ROI Telemetry Becomes the Moat: Imaging AI Shifts From ‘Accuracy’ to Measurable Capacity + Revenue (Feb 6, 2026)
ONE BIG THING Imaging AI crossed a commercial Rubicon this week: reimbursement tightened (NGS draft noncoverage for brain MRI AI quantification) while “ROI telemetry” emerged as the winning sales language—AI is increasingly bought as measurable capacity-and-revenue infrastructure, not a standalone accuracy feature. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK ROI telemetry becomes the moat”: […]
Markintel Pulse Insights — Imaging AI Becomes Infrastructure: Foundation Models + Outcome-Grade Evidence (Jan 30, 2026)
ONE BIG THING Randomized, population-scale evidence now shows AI-supported mammography can reduce interval cancers while materially lowering radiologist reading workload, pushing imaging AI from “pilot productivity tool” to quality-and-capacity infrastructure for national screening programs. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK Outcomes-grade screening AI becomes a capacity lever, not just a detection tool This […]
Markintel Pulse Insights — Radiology AI Shifts from Apps to Platforms (Jan 23, 2026)
ONE BIG THING Imaging AI is splitting into two winning lanes—multi‑indication “operational triage” that earns enterprise budgets and clearances, and a GenAI “explainability layer” forced by transparency rules—while payer scrutiny tightens the bar for anything that can’t prove measurable outcomes. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK The “Explainability Layer” Becomes the New ROI […]
Markintel Pulse Insights — MRI Automation Becomes the Capacity Lever – JAN 16, 2026
ONE BIG THING Imaging AI’s “center of value” moved upstream this week—away from interpretation-only tools and toward acquisition automation + open foundation models that directly translate into throughput, staffing leverage, and faster access. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK MRI demand continues rising while technologist scarcity and protocol complexity cap throughput. This week’s […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – JAN 9, 2026
ONE BIG THING FDA’s Jan‑6 guidance pair (CDS + General Wellness) materially widens the “non‑device” lane for AI in care delivery—shifting near‑term advantage from model performance to defensible deployment economics (workflow fit, evidence, liability controls, and integration). KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK Bedside imaging is becoming an economic weapon For imaging providers, […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – DEC 19, 2025
ONE BIG THING Imaging AI is shifting from “algorithm shelfware” to system-level workflow infrastructure — and this week’s mix of foundation-model progress, enterprise neuro workflow partnerships, and cath-lab AI M&A signals a platform land-grab that will redefine how imaging revenue is captured (through throughput, pathways, and coordination), not just per-study detection accuracy. KEY TAKEAWAYS MARKETSTRAT […]
